Lower Urinary Tract Symptoms
Study documents significant improvements in frequency, urgency, and nocturia.
Three quarters of patients experienced significant improvements in lower urinary tract symptoms and quality of life observed and were satisfied with treatment.
Men receiving common medical treatments for LUTS/BPH, including phytotherapy, experienced similar symptom relief.
The risk is 67% higher in men with a prostate size of 40.1-80 mL than those with smaller glands.
The risk of bladder outlet obstruction increased 34% per unit increase in serum PSA and decreased 23% per unit increase in maximal flow rate.
A recent review found little evidence to support severe lower urinary tract symptoms as a contraindication to TRT.
Use of high-velocity saline streams show promise in a small, first-in-man study.
Prostatic urethral lift is minimally invasive and, according to a new study, the procedure's beneficial effects are durable out to 3 years.
Overall, men with LUTS showed remarkably poor knowledge about their symptoms.
Men who reported having severe lower urinary tract symptoms (LUTS) had a 64% increased risk of the malignancy compared with those who reported no LUTS.
Vancouver Symptom Score linked to bullying victimization and perpetrator scores
Metabolic syndrome linked to severity of LUTS; symptoms improve after bariatric surgery
UroLift offers minimally-invasive treatment of benign prostatic hyperplasia (BPH) without risk of sexual dysfunction.
Sitting to urinate is associated with an improved urodynamic profile in lower urinary tract symptoms (LUTS).
Many urologists not uniformly adhering to AUA guidelines for the management of benign prostatic hyperplasia/lower urinary tract symptoms.
Men with diabetic peripheral neuropathy have an increased occurrence of erectile dysfunction and lower-urinary-tract symptoms.
Only 10% of men aged 45-69 years who progress from no or mild to moderate or severe lower urinary tract symptoms are treated, study finds.
Compared with standing, sitting was associated with significantly lower post-void residual volume.
Ejaculatory function worsens, however, in men taking 5 alpha-reductase inhibitors.
Range of risk factors identified for incidence and remission of ED, dyadic and solitary sexual desire.
About 30 percent of men experience an AUA symptoms index improvement of 3 or more points.
Improvements observed in urinary symptoms and bone mineral density.
Men with a body mass index of 30 kg/m2 or higher had a 39.3% prevalence of low testosterone, study finds.
Significant declines in International Prostate Symptom Score observed, regardless of whether or not men lost weight or used a phosphodiesterase-5 inhibitor.
Desmopressin appears to reduce nocturia and other LUTS while also significantly increasing testosterone levels in late-onset hypogonadism.
Study results underscore the need for additional research to find other surrogate markers of urinary infection.
Lower urinary tract symptoms actually improved in many men, with minimal change in PSA level.
Lower urinary tract symptoms (LUTS) are commonly attributed to benign prostatic hyperplasia.
Saw palmetto remains the most common herbal treatment for men with LUTS.
Orange or grapefruit juice consumption may be protective in men, study finds.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)